[Hemostasis disorders in obstetrics and gynecology].

Abstract:

:A survey is given on the clinical important haemostatic facts and diseases in gynaecology and obstetrics from the viewpoint of the gynecologist and obstetrician.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Heilmann L

doi

10.1267/hämo04040252

keywords:

subject

Has Abstract

pub_date

2004-11-01 00:00:00

pages

252-60

issue

4

eissn

0720-9355

issn

2567-5761

pii

04040252

journal_volume

24

pub_type

杂志文章,评审
  • [Fibrin monomer and factor XIII: a new concept for unexplained intraoperative coagulopathy].

    abstract::Unexplained intraoperative coagulopathies continue to be a diagnostic and therapeutic dilemma. The pathophysiology behind unexplained intraoperative coagulopathies is of great variety and complexity (preexisting coagulopathies, dilutional coagulopathy, interactions of medications etc.). We have shown in prospective st...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Korte W

    更新日期:2006-08-01 00:00:00

  • [Laboratory diagnosis of the lupus anticoagulants].

    abstract::The antiphospholipid syndrome is defined as the occurrence of one or more episodes of vascular thrombosis and/or miscarriage together with antiphospholipid antibodies. Some of these antibodies can be detected via coagulation assays by prolonging phospholipids-dependent assays. These unspecific inhibitors are termed lu...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo05010050

    authors: Quehenberger P,Wagner O

    更新日期:2005-02-01 00:00:00

  • [Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa].

    abstract::Replacement therapy of coagulation factor preparations (AT, FFP, PPSB, FXIII, rFVIIa) are frequently used on the Intensive Care Units. Indications, dosage, specific effects and side effects have to be considered. ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1267/hämo05020209

    authors: Scharrer I

    更新日期:2005-05-01 00:00:00

  • Health Care Transition of Adolescents and Young Adults with Haemophilia: the Situation in Germany and the Munich experience.

    abstract::Patients suffering from haemophilia encounter various phases in life, in which individual needs, life situations, and self- and disease perception change rapidly. One of these phases spans from the beginning of puberty until early adulthood, in which individuals gain self-responsibility and reach independence and auto...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-3402804

    authors: Bidlingmaier C,Olivieri M,Schilling FH,Kurnik K,Pekrul I

    更新日期:2020-02-01 00:00:00

  • Diagnosis and treatment of superficial vein thrombosis.

    abstract::Superficial vein thrombosis (SVT) is a common disease, characterized by an inflammatory-thrombotic process in a superficial vein. Typical clinical findings are pain and a warm, tender, reddish cord along the vein. Until recently, no reliable epidemiological data were available. The incidence is estimated to be higher ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-13-04-0027

    authors: Bauersachs RM

    更新日期:2013-08-01 00:00:00

  • Chromogenic substrates as fundamental tool to design new thrombin inhibitors. Determination of inhibition equilibrium constants.

    abstract::The structure-activity relationship of dipetalogastin II, the strongest thrombin inhibitor isolated and cloned from the bug Dipetalogaster maximus, was examined by introducing gradual changes into the molecule by means of molecular biological methods. The effect upon its inhibition equilibrium constant was determined ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1267/hämo05030267

    authors: Lopez M,Nowak G

    更新日期:2005-08-01 00:00:00

  • Feasibility and Results of a Mobile Haemophilia Outpatient Care Pilot Project.

    abstract:INTRODUCTION: Regular visits at haemophilia treatment centres (HTCs) in rural regions are often dependent on the access to a private car due to lack of or limited availability of public means. Therefore, a mobile haemophilia outpatient care (MHOC) concept providing home visits to haemophilia patients has been developed...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1654721

    authors: Eichler H,Schleicher C,Heine S,Graf N,von Mackensen S

    更新日期:2018-08-01 00:00:00

  • [Factor XIII in man: a review].

    abstract::Activated by calcium and thrombin, factor XIII (FXIIIa) cross-links fibrin, thus increasing the stability of the fibrin clot. Furthermore, the hemostatic and reparative function of factor XIIIa is mediated by cross-linking other proteins like alpha(2)-plasmin-inhibitor, fibronectin, and collagen. The FXIII Val34Leu po...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Dufner GS,Marbet GA

    更新日期:2002-02-01 00:00:00

  • Potential Drug Interactions between Recombinant Interleukin-2 and Direct Oral Anticoagulants: Indirect Evidence from In Vivo Animal Studies.

    abstract::Recombinant interleukin-2 (rIL-2) is indicated for metastatic renal cell carcinoma and melanoma. Over recent years low-dose rIL-2 has been studied for the treatment of autoimmune diseases and acute coronary syndrome because of its ability to expand and activate T regulatory (Treg) cells. However, several medical condi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1120-4064

    authors: Mahmoudpour SH,Valerio L,Douxfils J,Mahan CE,Jankowski M,Quitzau K,Konstantinides SV,Barco S

    更新日期:2020-12-01 00:00:00

  • [Identification of risk genes for myocardial infarction by genome wide association studies].

    abstract::Myocardial infarction (MI) shows a strong heritability. For a long time the identification of responsible genes has been rather unsuccessful. However, with the advent of genome wide association studies (GWAS) using DNA-array technology a number of significant loci for MI have been identified which were widely replicat...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Linsel-Nitschke P,Erdmann J,Schunkert H

    更新日期:2010-11-01 00:00:00

  • Management of acquired haemophilia A.

    abstract::Acquired haemophilia A (AHA) is caused by autoantibody inhibitors of coagulation factor VIII (FVIII : C). Recent onset of bleeds and isolated prolongation of the activated partial thromboplastin time (aPTT) are characteristic features of the disorder. Reduced FVIII : C activity and a detectable FVIII : C inhibitor in ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0064

    authors: Tiede A,Scharf RE,Dobbelstein C,Werwitzke S

    更新日期:2015-01-01 00:00:00

  • [Documentation of haemophilia treatment supported by the German Hemophilia Registry].

    abstract::The DHR (Deutsches Hämophilieregister, German Haemophilia Register) records patient data on haemophilia A, haemophilia B, von Willebrand disease, and other coagulation factor deficiency disorders. The DHR has been online since 2009. The participation in the DHR leads to additional administrative workload for the hospi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Haschberger B,Hesse J,Heiden M,Seitz R,Schramm W

    更新日期:2010-11-01 00:00:00

  • [Risk assessment of recurrence of venous thromboembolism].

    abstract::Recurrent venous thromboembolism is associated with increased mortality in 5-9% of the patients. On the other hand prolonged anticoagulation can increase the bleeding risk which can also be responsible for an increased mortality. Therefore, it is necessary to validate the recurrence risk of venous thromboembolism on a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1144

    authors: Lindhoff-Last E

    更新日期:2011-02-01 00:00:00

  • Methylation analysis of the promoter region and intron 1 of the factor VIII gene in haemophilia A patients.

    abstract::Methylation, CpG island, promoter, intron 1 Haemophilia A is the most common X-linked inherited coagulation disorder caused by a deficiency of the factor VIII protein (FVIII). A plethora of different mutations in the factor VIII gene (F8) have been identified as causative for this bleeding disease including a few prom...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Zimmermann MA,Hansmann T,Haaf T,Oldenburg J,Müller CR,Rost S

    更新日期:2013-01-01 00:00:00

  • Vitamin K antagonists. Ready to be replaced?

    abstract::For the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flaw...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-12050008

    authors: Steffel J,Luscher TF

    更新日期:2012-01-01 00:00:00

  • The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.

    abstract::Coronary heart disease and stroke, the deadliest forms of cardiovascular disease (CVD), are mainly caused by atherosclerosis, a chronic inflammatory disease of the artery wall driven by maladaptive immune responses in the vessel wall. Various risk factors for CVD influence this pathogenic process, including diabetes m...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-10-0052

    authors: Polyzos KA,Ketelhuth DF

    更新日期:2015-01-01 00:00:00

  • [Update of INR-selfmonitoring].

    abstract::Nearly every second patient, who needs an oral anticoagulation with vitamin K antagonists, is feasible to perform INR-self-management after participation in a structured teaching program. Patient self-testing or measuring the INR value by relatives or nurses would increase this method of control by the aid of telemedi...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Völler H,Braun S

    更新日期:2008-10-01 00:00:00

  • DOAC use in patients with chronic kidney disease.

    abstract::Direct oral anticoagulants (DOACs) are increasingly prescribed substances in patients with indication for effective anticoagulation. Patients with chronic kidney disease (CKD) have a high burden of cardiovascular risk and are more likely to develop atrial fibrillation (AF) than patients without CKD. Patients with mild...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-17-01-0003

    authors: Kcükköylü S,Rump LC

    更新日期:2017-01-01 00:00:00

  • [Antithrombotic therapy of acute coronary syndromes].

    abstract::Recent advances in the diagnosis and the treatment of acute coronary syndromes (ACS) have led to a substantial reduction of major coronary events, to an improvement in patient outcome and the definition of new guidelines. Current strategies for the treatment of patients with non-ST-elevation ACS recommend a combined a...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Hölschermann H

    更新日期:2007-12-01 00:00:00

  • Do we need antiplatelet therapy in thrombocytosis? Pro. Diagnostic and pathophysiologic considerations for a treatment choice.

    abstract::Thrombocytosis (defined as platelets >450 x 109/l) has several aetiologies. After having excluded spurious thrombocytosis (e. g., due to microspherocytes, schistocytes, cryoglobulins, or bacteria), the differential diagnosis of true thrombocytosis encompasses secondary causes (as diverse as inflammation, infection, ma...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0074

    authors: Alberio L

    更新日期:2016-11-07 00:00:00

  • [Recurrent miscarriage or failed in-vitro fertilization: antibodies against annexin V, cardiolipin, beta-2-glycoprotein-1 and APC-resistance].

    abstract:UNLABELLED:Antibodies against annexin-V, a potent anticoagulant abundant in placental tissues, were recently controversially reported to be associated with recurrent miscarriages or failures of in-vitro-fertilization (IVF) attempts. PATIENTS, MATERIAL, METHODS:We screened 56 women (34.7 +/- 4.3 years of age: mean +/- ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Halbmayer WM,Feichtinger W,Kindermann C,Prendinger B,Böhm M

    更新日期:2005-11-01 00:00:00

  • Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant.

    abstract::Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder affecting lysosome-related organelles (LRO), including dense platelet granules. HPS causes oculocutaneous hypopigmentation, bleeding diathesis and granulomatous colitis or pulmonary fibrosis. To date, there is no curative treatment and the clinica...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-06-0024

    authors: Sánchez-Guiu I,Torregrosa JM,Velasco F,Antón AI,Lozano ML,Vicente V,Rivera J

    更新日期:2014-01-01 00:00:00

  • Orthopedic approach of haemophiliacs. A single center experience in Romania.

    abstract:UNLABELLED:Clinical expression of inadequately treated haemophilia is dominated by orthopedic complications, requiring invasive or non-invasive interventions. OBJECTIVE:In Romania, with under dosed and late introduced "on demand" substitution, we aimed at highlighting the experience of orthopedic treatment and its out...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Serban M,Mihailov MD,Poenaru D,Pop L,Branea I,Bataneant M,Lăcătuşu A,Barna L,Tepeneu N,Schramm W

    更新日期:2008-10-01 00:00:00

  • [Future potential indications for an oral thrombin inhibitor].

    abstract::By the use of conventional anticoagulants, significant improvements were achieved in all fields of medicine. Although efficacious and widely used, their use is limited in several respects. In particular, the use of vitamin K antagonists is restricted in the clinical routine setting. The main reasons are the delayed on...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Haas S

    更新日期:2002-08-01 00:00:00

  • [Inhibitor development after changing FVIII/IX products in patients with haemophilia].

    abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kocher S,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2012-01-01 00:00:00

  • Dabigatran for stroke prevention in atrial fibrillation.

    abstract::Dabigatran is a novel direct thrombin inhibitor that has recently been approved for primary and secondary stroke prevention and prevention of systemic embolism in patients with atrial fibrillation. In the pivotal RE-LY study, dabigatran 110 mg BID was demonstrated to be associated with a stroke rate similar to that ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/ha-1196

    authors: Hohnloser SH,Diener HC

    更新日期:2012-01-01 00:00:00

  • Clot waveform analysis in patients with haemophilia A.

    abstract:UNLABELLED:Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. PATIENTS, METHOD:In this study the feasibility o...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-02-0016

    authors: Siegemund T,Scholz U,Schobess R,Siegemund A

    更新日期:2014-01-01 00:00:00

  • Phospholipid inhibitors. State of the art.

    abstract::The antiphospholipid syndrome (APS) is defined by the association of arterial and/or venous thrombosis and/or pregnancy complications with the presence of at least one among the main antiphospholipid antibodies (aPL) (i. e., Lupus anticoagulants, LA, IgG and/or IgM anticardiolipin antibodies, aCL, IgG and/or IgM antiβ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1165

    authors: Galli M

    更新日期:2011-11-01 00:00:00

  • Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire.

    abstract:AIM:In children, screening for haemorrhagic disorders is further complicated by the fact that infants and young children with mild disease in many cases most likely will not have a significant history of easy bruising or bleeding making the efficacy of a questionnaire even more questionable. PATIENTS, METHODS:We compa...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Music I,Novak M,Acham-Roschitz B,Muntean W

    更新日期:2009-10-01 00:00:00

  • [Monitoring of anticoagulants of secondary haemostasis].

    abstract::Vitamin K-antagonists and heparin belong to the established indirect acting anticoagulants. For many years these drugs were the only possibility for prophylaxis and treatment of venous and arterial thrombosis. The challenges for the routine laboratory related to the treatment with vitamin K-antagonists and heparin can...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Schuster B

    更新日期:2009-08-01 00:00:00